LIFEWARD LTD (LFWD) Stock News
NASDAQ:LFWD - Nasdaq - IL0011331076 - Common Stock - Currency: USD
LFWD Latest News, Press Relases and Analysis
Lifeward Appoints Mark Grant As New CEO: Retail Sentiment Dips
Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training.
Lifeward Names Mark Grant as New CEO
Industry veteran brings 30 years of commercial leadership experience...
Lifeward Names Mark Grant as New CEO
Industry veteran brings 30 years of commercial leadership experience
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward, Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a...
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
Lifeward Announces CEO Transition
CEO Larry Jasinski to Retire Company Begins Search for New Leader to Drive Next Phase of Growth Company Provides Preliminary Full-Year 2024 Revenue ...
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward (LFWD) delivered earnings and revenue surprises of -39.39% and 16.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ESTC
Lifeward Ltd. Reports First Quarter 2025 Financial Results
Lifeward Ltd. Reports First Quarter 2025 Financial Results
U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of...
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons...
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global...
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement...
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
Cooperation between Lifeward and Beilinson Hospital marks the first step towards a national policy in Israel on Exoskeleton training and procurement
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- Seventh generation of industry-leading personal exoskeleton is now...
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
FDA Issues Clearance for ReWalk 7 Exoskeleton
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury
FDA Issues Clearance for ReWalk 7 Exoskeleton
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury...
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
Record quarterly and annual revenue of $7.5M and $25.7M, respectively Continued strong growth in U.S. pipeline of ReWalk opportunities with over 110...
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
CorLife to become the exclusive distributor of the ReWalk Personal Exoskeleton for individuals with Workers’ Compensation claims ...
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
New Agreement Expands Distribution Rights to Lifeward to Include Referral Sales for Home Use Applications
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
New Agreement Expands Distribution Rights to Lifeward to Include Referral Sales for Home Use Applications...
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global...